Poly Medicure Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Poly Medicure Limited
Symbol
POLYMED
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Yes
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
30-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.polymedicure.com/annual-return-as-provided-under-section-92-of-the-companies-act-2013/
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://www.polymedicure.com/investor-information/schedule-audio-or-video-recordings-and-transcripts-of-analysts-or-institutional-investors-meet/?aiEnableCheckShortcode=true
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.polymedicure.com/newspaper-advertisements/\
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.polymedicure.com//wp-content/uploads/2020/09/Dividend-Distribution-Policy.pdf
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.polymedicure.com/wp-content/uploads/2023/02/Policy-for-determing-material-subsidiaries.pdf
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.polymedicure.com/subsidiaries-financials/
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://www.polymedicure.com/wp-content/uploads/2023/02/Credit-Rating-Report_Poly-Medicure-Ltd..pdf
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.polymedicure.com/about-us/
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.polymedicure.com/wp-content/uploads/2023/02/vigil-mechanism-and-whistle-blower-policy.pdf
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.polymedicure.com/financial-results/
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.polymedicure.com/wp-content/uploads/2023/02/Policy-for-determing-material-subsidiaries.pdf
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.polymedicure.com/wp-content/uploads/2023/02/policy-on-dealing-with-related-party-transactions.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.polymedicure.com/investor-information/
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.polymedicure.com/investor-information/
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.polymedicure.com/disclosures-under-regulation-46-of-lodr/
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.polymedicure.com/wp-content/uploads/2023/02/Disclosure-of-contact-details-of-key-managerial-personnel.pdf
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.polymedicure.com/disclosures-under-regulation-30-of-lodr/
Disclosure Web Link Of Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021Is Placed
https://www.polymedicure.com/wp-content/uploads/2025/07/ESOP-SCHEME-2020.pdf
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.polymedicure.com/wp-content/uploads/2026/04/MOA.pdf
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://www.polymedicure.com/investor-information/schedule-audio-or-video-recordings-and-transcripts-of-analysts-or-institutional-investors-meet/?aiEnableCheckShortcode=true
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.polymedicure.com/secretarial-compliance-report/
Disclosure Web Link Of Statements Of Deviations Or Variations As Specified In Regulation32Is Placed
https://www.polymedicure.com/investor-information/statement-of-deviation-and-variation/
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Yes
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE205C01021
Market Capitalisation As Per Immediate Previous Financial Year
Top 500 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
Not Applicable
Name Of Signatory
Avinash Chandra
Name Of Signatory Affirmations
Avinash Chandra
Name Of Signatory For Annual Affirmations
Avinash Chandra
Name Of Signatory For Quartely Affirmations
Avinash Chandra
Name Of The Company
POLY MEDICURE LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Number Of Cyber Security Incidence Or Breaches Or Loss Of Data Event Occurred During The Quarter
1
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
New Delhi
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
There is no loan or any other form of debt and any guarantee/ comfort letter (by whatever name called) provided by the listed entity directly or indirectly, in connection with any loan(s) or any other form of debt availed by the listed entity directly or indirectly to its Promoter or any other entity controlled by them / Promoter Group or any other entity controlled by them/ Directors (including relatives) or any other entity controlled by them/ KMPs or any other entity controlled by them during the financial year ended on 31st March, 2026
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
p00162
Scrip Code
531768
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Yes
Symbol
POLYMED
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Not Applicable
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
Yes
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_CyberSecurityIncidenceOrBreachesOrLossOfDataEvent1
Brief Details Of Cyber Security Incidence Or Breaches Or Loss Of Data Event
There was an incident of Cyber Attack on 15th February 2026 on a temporary data server located at company premises was used to send the data to third party. The server in question was not connected in any manner with the financial, production or any other important IT system within the organization. As part of our standard risk mitigation protocols, comprehensive verification measures have been undertaken, including system-wide security scans, cleanups, integrity checks, and validation procedures. These confirm that all environments under our control remain secure, sanitized, and fully functional. There has been no material impact on the financials of the company, its operations or business activities.
Date Of Cyber Security Incidence Or Breaches Or Loss Of Data Event
15-Feb-2026
Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionSpecial Resolution DateInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrDEVENDRA RAJ MEHTA******01067895Non-Executive - Non Independent DirectorChairperson25-Jun-1937NoActiveYes26-Sep-202423-Sep-201426-Sep-20241010
2MrHIMANSHU BAID******00014008Executive DirectorNot ApplicableMD08-Jun-1968NoActiveNot Applicable01-Apr-199526-Sep-20243120
3MrRISHI BAID******00048585Executive DirectorNot Applicable02-Jun-1972NoActiveNot Applicable01-Apr-199526-Sep-20241010
4MrJUGAL KISHORE BAID******00077347Non-Executive - Non Independent DirectorNot Applicable30-Mar-1942NoActiveYes26-Sep-202220-May-199525-Sep-20251000
5MrALESSANDRO BALBONI******08119143Non-Executive - Non Independent DirectorNot Applicable25-Oct-1961NoActiveNot Applicable10-May-201826-Sep-20241000
6MrAMIT KHOSLA******00203571Non-Executive - Independent DirectorNot Applicable05-Mar-1974NoActiveNot Applicable05-Jun-202025-Sep-202569.261122
7MsSONAL MATTOO******00106795Non-Executive - Independent DirectorNot Applicable29-Jan-1974NoActiveNot Applicable29-Aug-202025-Sep-202567.031100
8MrAMBRISH MITHAL******09618459Non-Executive - Independent DirectorNot Applicable29-Mar-1958NoActiveNot Applicable04-Aug-202229-Sep-202243.281100
9MrVIMAL BHANDARI******00001318Non-Executive - Independent DirectorNot Applicable23-Aug-1958NoActiveNot Applicable22-Jul-202426-Sep-202420.084453
10MrVISHAL GUPTA******00097939Non-Executive - Independent DirectorNot Applicable02-Feb-1974NoActiveNot Applicable28-Oct-202424-Jan-202517.032120
11MrVISHAL BAID******00232727Executive DirectorNot Applicable28-Aug-1974NoActiveNot Applicable06-May-202505-Aug-20251000
12MrPANKAJ KUMAR GUPTA******11232604Executive DirectorNot Applicable09-Sep-1967NoActiveNot Applicable08-Aug-202525-Sep-20251000

Committee Disclosures

Entry CompComit122
Date of Appointment
15-May-2014
Entry CompComit123
Date of Appointment
15-May-2014
Entry CompComit124
Date of Appointment
25-May-2022
Entry CompComit14
Date of Appointment
26-Sep-2024
Entry CompComit15
Date of Appointment
13-Feb-2018
Entry CompComit16
Date of Appointment
08-Aug-2025
Entry CompComit41
Date of Appointment
22-Jul-2024
Entry CompComit42
Date of Appointment
26-May-2005
Entry CompComit43
Date of Appointment
24-May-2022
Entry CompComit68
Date of Appointment
26-Sep-2024
Entry CompComit69
Date of Appointment
20-Sep-2002
Entry CompComit70
Date of Appointment
27-Oct-2015
Entry CompComit71
Date of Appointment
08-Aug-2025
Entry CompComit95
Date of Appointment
24-May-2022
Entry CompComit96
Date of Appointment
05-Jun-2022
Entry CompComit97
Date of Appointment
05-Jun-2020
Entry CompComit98
Date of Appointment
08-Aug-2025
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.polymedicure.com/wp-content/uploads/2026/04/Committee-Position-1.pdf
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
00203571
Member Name
AMIT KHOSLA
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
01067895
Member Name
DEVENDRA RAJ MEHTA
Position
Non-Executive - Non Independent Director

Audit Committee

Additional Position
Member
Director DIN
00001318
Member Name
VIMAL BHANDARI
Position
Non-Executive - Independent Director

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
01067895
Member Name
DEVENDRA RAJ MEHTA
Position
Non-Executive - Non Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00077347
Member Name
JUGAL KISHORE BAID
Position
Non-Executive - Non Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00106795
Member Name
SONAL MATTOO
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00106795
Member Name
SONAL MATTOO
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
01067895
Member Name
DEVENDRA RAJ MEHTA
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00203571
Member Name
AMIT KHOSLA
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Risk Management Committee

Additional Position
Chairperson
Director DIN
00106795
Member Name
SONAL MATTOO
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
00048585
Member Name
RISHI BAID
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00014008
Member Name
HIMANSHU BAID
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00001318
Member Name
VIMAL BHANDARI
Position
Non-Executive - Independent Director

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
00203571
Member Name
AMIT KHOSLA
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00014008
Member Name
HIMANSHU BAID
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00048585
Member Name
RISHI BAID
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
00097939
Member Name
VISHAL GUPTA
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
08-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
11
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
12
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
05-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
88
Number Of Directors Present In Meeting Of Board Of Directors
12
Number Of Independent Directors Attending The Meeting
5
Total Number Of Directors As On Date Of The Meeting
12
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
08-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
05-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
88
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
05-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
05-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
06-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
0
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
0
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.polymedicure.com/investor-information/
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://www.polymedicure.com/investor-information/
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
0
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
There is no acquisition of share or voting rights of any unlisted company during the quarter ended on 31st March, 2026
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Reason For Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Not Applicable To The Entity
There is no ongoing tax litigation or dispute during the quarter ended on 31st March, 2026
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
No
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
There is no imposition of fine or penalty during the quarter ended on 31st March, 2026
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No